Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Avient Corporation (AVNT) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Avient CorporationTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Avient Corporation vs Intuitive Surgical, Inc. — how do they compare? Avient Corporation trades at $36.11 (market cap $3.28B), while Intuitive Surgical, Inc. trades at $391.35 (market cap $134.40B). The key difference: Intuitive Surgical, Inc. is far larger — about 41× Avient Corporation's market cap, and Avient Corporation pays a 3.07% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.

AVNTISRG
Market Cap
$3.28B$134.40B
Sector
TechnologyHealth
52-Week High
$43.28$592.85
52-Week Low
$27.48$379.50
Enterprise Value
$4.78B$129.89B
Dividend Yield
3.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Avient Corporation

Avient Corporation (AVNT) trades at $35.57, down 1.28% with a bearish technical signal. The company shows consistent earnings beats with Q1 2026 EPS of $0.83 exceeding expectations. Fundamentals reveal a P/E of 20.79 and net income margin of 4.81%, while cash flow trends improved from -$34M in 2025 to -$28M projected for 2026. Recent developments include new product launches and ClassNK approval for Dyneema DM20 fiber, supporting growth in renewable energy markets.

AVNT presents a mixed outlook with strong analyst support (60% buy ratings) offset by near-term technical weakness. The company's innovation pipeline and cost control measures provide upside potential, though macroeconomic headwinds and competitive pressures remain key risks. Earnings growth and successful market expansion of new technologies are critical catalysts for stock performance.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $407.12, showing minimal daily change. The stock is in a bearish technical trend but maintains strong fundamentals with consistent revenue growth, expanding profit margins, and a history of earnings beats. Recent news highlights near-term headwinds and a significant decline from 52-week highs, yet analyst sentiment remains largely positive, focusing on long-term robotic surgery market penetration.

The outlook balances strong fundamentals against technical weakness. Investment opportunity lies in market leadership and earnings growth potential, but risks include competitive pressures and execution challenges. Wall Street consensus is bullish with a $557.60 price target, suggesting substantial upside if the company navigates current challenges successfully.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Avient Corporation

Avient Corporation is a global leader in specialized and sustainable material solutions. Formed from the legacy of PolyOne and Clariant’s masterbatch business, it provides highly engineered polymer formulations, color systems, and advanced composites that enhance the performance and sustainability of products in industries like healthcare, defense, and consumer packaging.

Read more on AVNT

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG